| NCT ID | NCT06963567 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Queen Mary University of London |
| Condition | Left Ventricular Thrombus |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2024-05-17 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2024-05-17 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Left Ventricular Thrombus (LVT) is a blood clot that can develop in a poorly functioning heart. In around 1 in 6 patients who have had a heart attack or diagnosed with heart failure tend to develop blood clots in their main heart chamber. Having a blot clot in the main heart chamber can lead to serious complications such as stroke. Treatment for blood clots is blood thinning medications, which if taken for a prolonged period of time can result in bleeding which further complicates treatment. We hope to gather information to better understand the factors associated with blood clot formation and management in the lower left chamber of the heart. This understanding will hopefully enable us and others to improve management of this condition in the future and therefore help the wider population. As part of this study, bloods and scan results will be recorded and we will complete a short quality of life questionnaire. When participants come in for routine MRI scan, we may capture additional images for further research analysis. A sample of blood no more than one tablespoon will be collected for research analysis at the same time as routine blood test. This will occur at baseline and at around 6 months. At 12 months we will repeat the quality of life questionnaire and collect final data.
Eligibility Criteria
Inclusion Criteria: * Patients with LV thrombus or; * Patients at risk for developing LV thrombus (e.g severe LV dysfunction, LV aneurysm, MI. Exclusion Criteria: * Age \< 18 years * Unable to consent
Frequently Asked Questions
Who can join the NCT06963567 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Left Ventricular Thrombus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06963567 currently recruiting?
Yes, NCT06963567 is actively recruiting participants. Visit ClinicalTrials.gov or contact Queen Mary University of London to inquire about joining.
Where is the NCT06963567 trial being conducted?
This trial is being conducted at Cambridge, United Kingdom, London, United Kingdom, Middlesbrough, United Kingdom, Sunderland, United Kingdom and 4 additional locations.
Who is sponsoring the NCT06963567 clinical trial?
NCT06963567 is sponsored by Queen Mary University of London. The trial plans to enroll 1,500 participants.